Hibicet Hospital Concentrate

Land: Neuseeland

Sprache: Englisch

Quelle: Medsafe (Medicines Safety Authority)

Wirkstoff:

Cetrimide 15%{relative} (37.5%w/v of 40% solution); Chlorhexidine gluconate 1.5%{relative} (7.8% of 20% solution (includes 4% overage))

Verfügbar ab:

AstraZeneca Limited

INN (Internationale Bezeichnung):

Cetrimide 15% w/v (37.5%w/v of 40% solution)

Darreichungsform:

Topical solution

Zusammensetzung:

Active: Cetrimide 15%{relative} (37.5%w/v of 40% solution) Chlorhexidine gluconate 1.5%{relative} (7.8% of 20% solution (includes 4% overage)) Excipient: Acid yellow 17 Benzyl benzoate Brown FK Isopropyl alcohol Deodorant Perfume Compound V3636 Purified water Terpineol

Einheiten im Paket:

Bottle, plastic, 5 L

Klasse:

General sale

Verschreibungstyp:

General sale

Hergestellt von:

AstraZeneca Pty Ltd

Produktbesonderheiten:

Package - Contents - Shelf Life: Bottle, plastic, - 5 L - 24 months from date of manufacture stored at or below 30°C

Berechtigungsdatum:

1986-07-14